Teva Respiratory, LLC
Teva Respiratory, LLC is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.
About Teva Respiratory, LLC
Teva Respiratory, LLC is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by RESLIZUMAB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: add-on maintenance, treatment patients, severe asthma, aged years, eosinophilic phenotype, relief acute, bronchospasm status, usage cinqair. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| RESLIZUMAB | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRAVENOUS | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Teva Respiratory, LLC
| Brand name | Generic | Type | Route |
|---|---|---|---|
| CINQAIR | RESLIZUMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
Frequently asked questions
How many FDA drug products does Teva Respiratory, LLC make?
1 FDA drug label records name Teva Respiratory, LLC as the manufacturer, covering 1 distinct active ingredients.
What active ingredients does Teva Respiratory, LLC produce?
The most frequent active ingredients in this portfolio are RESLIZUMAB.
Are Teva Respiratory, LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.